Positive earnings and consumer confidence have Brad McMillan bullish on stocks for 2017, so he's not concerned about any short-term pullbacks. » Read More
By: Alex Rosenberg
Citron Research's Thursday afternoon tweet sent shares of Express Scripts tanking, and someone appeared ideally positioned for the move. » Read More
By: Christine Wang
Earlier Thursday, Left's Citron Research called Express Scripts the "Philidor of the pharma industry." » Read More
Check out the companies making headlines after the bell Tuesday: Alphabet, Under Armour, Southwestern Energy and more.
Shares of Mallinckrodt and Mylan rose after the pharmaceutical companies posted better-than-expected quarterly earnings.
Investors managed to make it through April modestly ahead of the game, though individual returns were held back by one principal culprit: Apple.
Investors aiming to catch up with the strong market rally since the lows in February have missed the boat, JPMorgan strategists say.
Don't expect this gold rally to fizzle. Outspoken commodities expert Dennis Gartman believes the metal could be on the verge of going much, much higher.
Many of the factors hammering Apple's share price are temporary and can be reversed in less than a year, Kulbinder Garcha says.
Some of the names on the move ahead of the open.
Using Kensho, a hedge fund analytics tool, CNBC Pro screened for which securities will rise the most if Apple rallies.
Yahoo's management team and directors have given a warm welcome to Starboard Value Chief Executive Jeffrey Smith since he joined the company's board.
Sprint, the No.4 U.S. wireless carrier, said its quarterly revenue fell 2.5 percent as it gave big discounts to attract more subscribers.
An "application glitch" led some Vanguard clients to see an inflated account balance displayed on their Apple mobile devices, a spokeswoman said.
Jim Cramer spoke with Apple CEO Tim Cook on why he feels optimistic about the company's growth ahead.
Quintiles Transnational and IMS Health said they would merge, creating a company with a market value of more than $17.6 billion.
Jim Cramer spoke with Apple CEO Tim Cook about the one country that could be a game changer very soon.
Jim Cramer spoke with Apple CEO Tim Cook, who provided insight on getting ahead for the long term.
Hedge fund manager Bill Ackman defended his key holding Valeant Pharmaceuticals on Monday, as its shares continued to tumble.
Get the best of CNBC in your inbox